A prescription-only, next-generation antiviral medication manufactured by Getz Pharma to manage chronic Hepatitis B virus (HBV) infection in adults and adolescents.
Getinomide contains Tenofovir Alafenamide (TAF) 25mg, a highly targeted prodrug of tenofovir. It represents a major clinical advancement over older forms of tenofovir (like TDF found in Getino-B):
Targeted Hepatic Delivery: TAF is highly stable in the bloodstream. Instead of breaking down early in the blood, it enters hepatocytes (liver cells) intact by passive diffusion and specialized liver transporters.
Lower Systemic Exposure: Because it selectively targets the liver, a much smaller daily dose (25mg vs. 300mg of older TDF) is required to achieve the exact same antiviral punch. This leaves 90% less active drug circulating in the rest of your bloodstream.
Enzyme Interference & Termination: Once inside the liver cells, it is converted into its active state (tenofovir diphosphate). It blocks HBV DNA polymerase—the primary replication engine the virus uses to copy itself—and cuts off the viral DNA chain, stopping the virus from multiplying.
Enhanced Organ Safety: By minimizing systemic exposure, Getinomide significantly reduces the risk of long-term side effects on your kidneys and bones compared to older antiviral therapies.
Manufacturer: Getz Pharma (Private) Limited.
Nigerian Marketer: Getz Pharma Nigeria Limited.
NAFDAC Registration Number (NRN): C4-1296.
Therapeutic Class: Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI).
Pack Presentation: Standard high-barrier bottles containing 30 film-coated tablets (a full 1-month supply).
The Acute Hepatitis B Flare Warning: Never stop taking Getinomide abruptly or skip your daily doses. If you stop treatment without your doctor's guidance, your Hepatitis B infection can experience a sudden, severe flare-up. This can cause severe liver injury or acute liver failure. If therapy must be paused, your doctor will monitor your liver function closely for several months.
Undiagnosed HIV Co-infection: If you have both HIV and Hepatitis B, taking Getinomide alone is strictly contraindicated. Using a standalone mono-therapy can cause the hidden HIV strain to mutate and develop resistance to tenofovir, making the HIV far harder to treat later. Always confirm your HIV-negative status before starting this medication.
Lactic Acidosis & Severe Hepatotoxicity: Although less common with TAF, class warnings for nucleoside analogs remain. Discontinue use and contact your care team immediately if you develop symptoms of lactic acidosis (deep, rapid breathing, unusual muscle pain, cold limbs) or severe liver enlargement (yellow skin/eyes, dark urine, or severe right-upper abdominal pain).
The Food Consistency Rule: Getinomide should be taken with a meal or a small snack. Taking it alongside food optimizes how the drug is absorbed and processed by your digestive tract.
The Strict Daily Alarm: Take your tablet at the exact same hour every single day. Maintaining a fixed schedule ensures a steady baseline of defense in your system, preventing the virus from developing resistance.
1.Align your dose with a fixed daily meal:Timing Anchor.
Pick a consistent daily mealtime, such as breakfast or dinner, to take your tablet. This keeps your routine steady and builds optimal drug levels.
2.Swallow the tablet whole with water:Ingestion Mechanics.
Take one single 25mg tablet and swallow it whole with a full glass of plain water. Do not chew, crush, split, or dissolve the film-coated tablet.
3.Handle forgotten doses carefully:The 18-Hour Missed Dose Rule.
If you miss a dose and remember within 18 hours of your usual time, take it immediately with food. If more than 18 hours have passed, skip the missed dose entirely and wait for your next regular slot. Never take two tablets at once.
4.Take a replacement pill if lost early:Vomiting Backup.
If you experience a severe upset stomach and vomit within 1 hour of swallowing your tablet, take another replacement tablet immediately.
Getinomide is exceptionally well-tolerated due to its targeted nature, but a few individuals may experience minor, temporary adjustments:
Central nervous system updates, including mild headaches, dizziness, or a feeling of physical fatigue.
Digestive shifts, such as brief nausea, mild abdominal pain, vomiting, or diarrhea.
Localized musculoskeletal complaints, including minor back pain or temporary joint aches.
What makes Getinomide (TAF) better than standard Getino-B (TDF)?
While both medications are highly effective at suppressing the Hepatitis B virus, the older version (TDF) circulates at higher levels throughout the bloodstream, which can stress the kidneys and gently lower bone mineral density over years of use. Getinomide (TAF) targets the liver directly, using a much smaller dose to achieve identical results while offering superior safety profiles for your bones and kidneys.
How should this medication be stored?
Store Getinomide tablets in their original container below 30°C (86°F), away from excessive moisture and heat. Keep the bottle tightly closed and leave the small drying packet (desiccant) inside, as it protects the stability of the active film-coated tablets.
To guarantee you are not buying a counterfeit batch, always verify that the package displays the sharp Getz Pharma corporate logo and the specific NAFDAC number C4-1296. You can securely order factory-authenticated batches online via Sanlive Pharmacy & Stores for direct, climate-controlled delivery in Lagos, Abuja, and Port Harcourt.
Important Notice: This information is for educational support purposes only. Getinomide is a high-potency, prescription-only antiviral medication. Treatment must be initiated, monitored, and adjusted exclusively under the close supervision of a qualified gastroenterologist, hepatologist, or infectious disease specialist. Always complete regular liver function and viral load laboratory tests as requested by your clinical team.
No reviews yet — be the first!
Log in to write a review.